From: RNA sequencing of blood in coronary artery disease: involvement of regulatory T cell imbalance
Gene name | p value | Fold | Fold | Expression (RPKM) | Symbol | Description | RefSeq | ||
---|---|---|---|---|---|---|---|---|---|
HvsL | MvsL | HIGH | MID | LOW | |||||
uc061drv.1 | 2.93E−04 | 1.01↑ |  − 4.97↓ |  − 1.24 |  − 3.56 |  − 1.25 | A1BG | alpha-1-B glycoprotein | NM_130786 |
uc059ulu.1 | 5.07E−04 |  − 1.57↓ |  − 2.22↓ |  − 0.71 |  − 1.21 |  − 0.06 | BBS2 | Bardet–Biedl syndrome 2 | NM_031885 |
uc061wwa.1 | 6.36E−04 |  − 1.44↓ |  − 1.39↓ |  − 0.29 |  − 0.23 | 0.24 | BLCAP | Bladder cancer associated protein | NM_001167820 |
uc063nqr.1 | 3.79E−04 | 1.29↑ |  − 3.35↓ |  − 5.67 |  − 7.78 |  − 6.04 | C6orf10 | Chromosome 6 open reading frame 10 | NM_001286474 |
uc059xrj.1 | 1.45E−04 |  − 2.97↓ |  − 8.68↓ |  − 2.86 |  − 4.41 |  − 1.29 | CDH13 | Cadherin 13 transcript variant 5 | NM_001220491 |
uc064rqz.1 | 8.12E−04 |  − 1.46↓ |  − 1.57↓ | 0.09 |  − 0.01 | 0.64 | COMMD5 | COMM domain containing 5 | NM_001081004 |
uc060std.1 | 7.00E−04 | 1.21↑ |  − 6.37↓ |  − 2.71 |  − 5.66 |  − 2.99 | FBN3 | fibrillin 3 | NM_032447 |
uc058fep.1 | 6.63E−04 |  − 1.37↓ |  − 1.52↓ |  − 0.02 |  − 0.18 | 0.43 | FCHSD2 | FCH and double SH3 domains 2 | NM_014824 |
uc058vgw.1 | 2.07E−04 |  − 1.69↓ |  − 1.83↓ |  − 2.04 |  − 2.15 |  − 1.28 | MMP17 | Matrix metallopeptidase 17 | NM_016155 |
uc063sgp.1 | 7.99E−04 |  − 2.35↓ |  − 6.59↓ |  − 2.57 |  − 4.06 |  − 1.34 | MTHFD1L | Methylenetetrahydrofolate dehydrogenase 1L | NM_001242768 |
uc059rbn.1 | 8.11E−04 |  − 1.42↓ |  − 1.91↓ | 1.87 | 1.45 | 2.38 | PLA2G10 | Phospholipase A2, group X | NM_003561 |
uc063mxz.1 | 3.53E−04 |  − 4.06↓ |  − 5.22↓ |  − 3.46 |  − 3.82 |  − 1.44 | PSORS1C1 | Psoriasis susceptibility 1 candidate 1 | NM_014068 |
uc059xcn.1 | 9.57E−04 |  − 1.43↓ |  − 1.59↓ |  − 0.58 |  − 0.73 |  − 0.06 | RFWD3 | Ring finger and WD repeat domain 3 | NM_018124 |
uc062bvk.1 | 8.81E−04 |  − 1.52↓ |  − 1.42↓ |  − 0.80 |  − 0.69 |  − 0.19 | SERPIND1 | Serpin peptidase inhibitor D, heparin cofactor | NM_000185 |
uc001zwr.5 | 9.10E−04 | 1.02↑ | 1.67↑ | 0.59 | 1.30 | 0.56 | SLC12A1 | Solute carrier family 12A1 | NM_000338 |
uc064wao.1 | 3.99E−04 |  − 1.80↓ |  − 1.66↓ |  − 1.08 |  − 0.96 |  − 0.23 | SLC25A25 | Solute carrier family 25 A25 | NM_052901 |
uc063fxo.1 | 5.55E−04 | 1.02↑ |  − 1.81↓ | 0.47 |  − 0.41 | 0.44 | SLC25A46 | Solute carrier family 25 member 46 | NM_001303250 |
uc062iym.1 | 2.16E−04 |  − 2.20↓ |  − 1.14↓ |  − 0.19 | 0.76 | 0.95 | SLC6A20 | Solute carrier family 6 (proline transport) | NM_022405 |
uc061irb.1 | 5.78E−05 |  − 2.01↓ |  − 1.74↓ |  − 1.11 |  − 0.91 |  − 0.10 | THADA | Thyroid adenoma associated | NR_073394 |
uc060vxm.1 | 4.76E−06 |  − 3.08↓ |  − 10.76↓ |  − 2.48 |  − 4.28 |  − 0.86 | TMEM161A | TRANSMEMBRANE protein 161A | NM_001256766 |
uc061you.1 | 1.46E−04 |  − 1.45↓ |  − 1.61↓ |  − 0.91 |  − 1.07 |  − 0.38 | ZGPAT | Zinc finger, CCCH-type with G patch domain | NM_181485 |